Characterization of a FGF1-FGF21 chimeric protein with increased thermal stability and biological activities

by Phan, P.; Thallapuranam, S. K. K.

The family of fibroblast growth factor (FGF) is responsible for meditating various biological functions: wound healing, angiogenesis and glucose regulations. The FGF family is composed of endocrine, paracrine and intracrine FGFs. The paracrine FGFs, like FGF1, work locally through FGF receptors and heparin sulfate (HS) to regulate crucial activities like cell growth, differentiation, and tissue repairs. FGF1 has been investigated extensively and gave rise to a FGF1-variant termed SuperFGF1 (sFGF1). sFGF1 demonstrated increased thermal, chemical, and proteolytic stability, enhanced bioactivity. The endocrine FGF21 engages in distant physiological functions across various organs but does not require HS for activation. FGF21 has the ability to meditate glucose uptake in adipocytes and is an attractive therapeutic agent for type-2 diabetes. FGF21 has limitations low thermal stability, low receptor affinity, and an unstable core. Herein, we established a structure-based chimera protein by merging a thermally stable sFGF1 with the physiologically active FGF21 C-terminal. The protein’s intrinsic fluorescence spectra showed an emission maximum at 308 nm, indicating that the emission of the conserved tryptophan is not quenched. The chimera protein adopts a ß-trefoil motif through circular dichroism data. sFGF1-FGF21 is more thermally stable (64°C) than wild type FGF21 (44°C). The chimera protein also showed significant proliferative activities on NIH3T3 fibroblast cells at lower concentrations (10 ng/mL). sFGF1-FGF21 also exhibited some metabolic activities on 3T3-L1 adipocytes and increases the cells ATP production rates at lower concentrations (10 ng/mL). Limited trypsin digestion assay showed the chimera is prone to proteolytic cleavage, similar to FGF21.